Coronavirus Associated Pneumomediastinum and Pneumothorax
COVI-MIX
1 other identifier
observational
241
1 country
27
Brief Summary
Spontaneous pneumomediastinum (PMS) is defined as free air within the mediastinum. Spontaneous pneumothorax (PNX) consists of the presence of air inside the pleural space. PMS and PNX may sometimes occur secondly to an underlying pathology, or deriving from a sudden increase in intra-alveolar pressure such as functional alteration such as airway hyperactivity, Valsalva maneuver, cough, barotrauma, and/or volutrauma with consequent rupture of the alveoli and subsequent leakage of air into the mediastinum due to the Macklin effect. The escaping air can then spread inside the pericardium, the peritoneum, the muscles, and subcutaneous tissues, hence causing subcutaneous emphysema. PMS and PNX are rare complications of several lung infections such as Pneumocystis Jirovecii pneumonia, tuberculosis, bacterial necrotizing pneumonia, and herpes pneumonia. However, an increasing number of PMS and PNX has been described in patients with SARS-CoV2 interstitial pneumonia. PMS and PNX can either present as the onset manifestation of COVID-19 disease, or occur as complications of non-invasive and/or invasive ventilation, or following to cystic and/or fibrotic evolution of the pathology. The frequency of PMS and PNX during COVID-19 is not well defined, as the available data are limited to case collections and single reports. According to currently available scientific literature, PNX in COVID-19 occurs with frequency rates of 1-3%, up to 6% in patients undergoing non-invasive ventilation (NIV) and mechanical artificial ventilation (VAM). In McGuinness's analysis, which compared the complications of barotrauma in patients with acute respiratory distress syndrome (ARDS) in VAM, PNX and PMS occurred with frequency rates of 9% and 10%, respectively, while in non-COVID-19 population, PNX and PMS frequency rates were 12% and 3%, respectively.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Aug 2021
Shorter than P25 for all trials
27 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 18, 2021
CompletedFirst Posted
Study publicly available on registry
May 21, 2021
CompletedStudy Start
First participant enrolled
August 15, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 30, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
August 31, 2021
CompletedApril 15, 2022
April 1, 2022
15 days
May 18, 2021
April 10, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
Barotrauma occurrence with different respiratory strategies
Effect of the different respiratory support strategies on barotrauma (pneumomediastinum and/or pneumothorax) occurrence
February 20, 2020 - March 31, 2021
Secondary Outcomes (3)
Pneumomediastinum and pneumothorax
February 20, 2020 - March 31, 2021
Risk factors other than ventilation strategy
February 20, 2020 - March 31, 2021
30-day outcome
30 days
Eligibility Criteria
Hospitalized patients with SARS-COV2 infection
You may qualify if:
- Patients 18 years of age or older hospitalized with SARS-COV2 infection
You may not qualify if:
- Failure to obtain clinical or radiological information about the case
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (27)
Policlinico S.Orsola-Malpighi, Pneumologia e Terapia Intensiva Respiratoria
Bologna, Italy
Policlinico S.Orsola-Malpighi, U.O Malattie Infettive
Bologna, Italy
Azienda Ospedaliero-Universitaria V.Emanuele Ferrarotto, S.bambino, Malattie Infettive
Catania, Italy
Azienda Ospedaliero-Universitaria V.Emanuele Ferrarotto, S.bambino, U.O.C. di Malattie Infettive
Catania, Italy
Azienda Ospedaliera S.Croce e Carle Cuneo, SC Malattie Infettive e tropicali,
Cuneo, Italy
Ospedale Policlinico San Martino-IRCCS, Clinica di Malattie Infettive e Tropicali
Genova, Italy
Fondazione IRCCS, Ca Granda Ospedale Maggiore Policlinico, UOC, Malattie Infettive
Milan, Italy
Ospedale dei colli, Malattie Infettive ed Urgenze Infettivologiche,
Napoli, Italy
Azienda Ospedaliera di Padova, S.C di Fisiopatologia respiratoria,
Padua, Italy
Unità Operativa Complessa Istituto di Anestesia e Rianimazione dell'Azienda Ospedale-Università di Padova,
Padua, Italy
Azienda Ospedaliera Universitaria Policlinico Paolo Giaccone di Palermo, UOC Anestesia Rianimazione con Terapia Intensiva Polivalente e del Dolore
Palermo, Italy
Azienda Ospedaliero-Universitaria di Parma, Clinica Pneumologica
Parma, Italy
Azienda Ospedaliera Perugia, Malattie Infettive
Perugia, Italy
Azienda USL Toscana Ovest, Ospedale Felice Lotti SOC Medicina Interna
Pontedera, Italy
Azienda Sanitaria Universitaria Friuli Occidentale, S.C Pneumologia
Pordenone, Italy
AOU Città della Salute e Scienza, SC Malattie Infettive
Torino, Italy
Azienda Ospedaliera Ordine Mauriziano S.C. Pneumologia e Unità di Terapia Semi Intensiva Respiratoria
Torino, Italy
Ospedale Cardinal Massaia, SC Malattie Infettive
Torino, Italy
Azienda Sanitaria Universitaria Giuliano Isontina, S.C Pneumologia
Trieste, Italy
Anesthesiology and Intensive Care Clinic - Department of Medicine - ASUIUD
Udine, 33100, Italy
Azienda ospedaliero universitaria Friuli Centrale, Anestesia e Rianimazione 1
Udine, Italy
Azienda ospedaliero universitaria Friuli Centrale, Anestesia e Rianimazione 2
Udine, Italy
Azienda ospedaliero universitaria Friuli Centrale, Clinica di Anestesia e Rianimazione
Udine, Italy
Azienda Ospedaliero Universitaria Friuli Centrale, Malattie infettive
Udine, Italy
Azienda Ospedaliero Universitaria Friuli Centrale, Pneumologia
Udine, Italy
Azienda Sanitaria locale di Vercelli, Malattie infettive
Vercelli, Italy
Università di Verona, Clinica delle Malattie Infettive e Tropicali
Verona, Italy
Related Publications (6)
Maunder RJ, Pierson DJ, Hudson LD. Subcutaneous and mediastinal emphysema. Pathophysiology, diagnosis, and management. Arch Intern Med. 1984 Jul;144(7):1447-53.
PMID: 6375617BACKGROUNDWang W, Gao R, Zheng Y, Jiang L. COVID-19 with spontaneous pneumothorax, pneumomediastinum and subcutaneous emphysema. J Travel Med. 2020 Aug 20;27(5):taaa062. doi: 10.1093/jtm/taaa062.
PMID: 32330274BACKGROUNDChen N, Zhou M, Dong X, Qu J, Gong F, Han Y, Qiu Y, Wang J, Liu Y, Wei Y, Xia J, Yu T, Zhang X, Zhang L. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020 Feb 15;395(10223):507-513. doi: 10.1016/S0140-6736(20)30211-7. Epub 2020 Jan 30.
PMID: 32007143BACKGROUNDYao W, Wang T, Jiang B, Gao F, Wang L, Zheng H, Xiao W, Yao S, Mei W, Chen X, Luo A, Sun L, Cook T, Behringer E, Huitink JM, Wong DT, Lane-Fall M, McNarry AF, McGuire B, Higgs A, Shah A, Patel A, Zuo M, Ma W, Xue Z, Zhang LM, Li W, Wang Y, Hagberg C, O'Sullivan EP, Fleisher LA, Wei H; collaborators. Emergency tracheal intubation in 202 patients with COVID-19 in Wuhan, China: lessons learnt and international expert recommendations. Br J Anaesth. 2020 Jul;125(1):e28-e37. doi: 10.1016/j.bja.2020.03.026. Epub 2020 Apr 10.
PMID: 32312571BACKGROUNDMcGuinness G, Zhan C, Rosenberg N, Azour L, Wickstrom M, Mason DM, Thomas KM, Moore WH. Increased Incidence of Barotrauma in Patients with COVID-19 on Invasive Mechanical Ventilation. Radiology. 2020 Nov;297(2):E252-E262. doi: 10.1148/radiol.2020202352. Epub 2020 Jul 2.
PMID: 32614258BACKGROUNDVetrugno L, Castaldo N, Fantin A, Deana C, Cortegiani A, Longhini F, Forfori F, Cammarota G, Grieco DL, Isola M, Navalesi P, Maggiore SM, Bassetti M, Chetta A, Confalonieri M, De Martino M, Ferrari G, Francisi D, Luzzati R, Meini S, Scozzafava M, Sozio E, Tascini C, Bassi F, Patruno V; Italian COVI-MIX Study Group; De Robertis E, Aldieri C, Ball L, Baratella E, Bartoletti M, Boscolo A, Burgazzi B, Catalanotti V, Confalonieri P, Corcione S, De Rosa FG, De Simoni A, Bono VD, Tria RD, Forlani S, Giacobbe DR, Granozzi B, Labate L, Lococo S, Lupia T, Matellon C, Mehrabi S, Morosi S, Mongodi S, Mura M, Nava S, Pol R, Pettenuzzo T, Quyen NH, Rescigno C, Righi E, Ruaro B, Salton F, Scabini S, Scarda A, Sibani M, Tacconelli E, Tartaglione G, Tazza B, Vania E, Viale P, Vianello A, Visentin A, Zuccon U, Meroi F, Buonsenso D. Ventilatory associated barotrauma in COVID-19 patients: A multicenter observational case control study (COVI-MIX-study). Pulmonology. 2023 Nov-Dec;29(6):457-468. doi: 10.1016/j.pulmoe.2022.11.002. Epub 2022 Nov 24.
PMID: 36669936DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Clinical Professor in Anesthesiology and Intensive Care
Study Record Dates
First Submitted
May 18, 2021
First Posted
May 21, 2021
Study Start
August 15, 2021
Primary Completion
August 30, 2021
Study Completion
August 31, 2021
Last Updated
April 15, 2022
Record last verified: 2022-04